Primary sclerosing cholangitis associated colitis: Characterization of clinical, histologic features, and their associations with liver transplantation

被引:12
作者
Aranake-Chrisinger, John [1 ]
Dassopoulos, Themistocles [2 ]
Yan, Yan [3 ,4 ]
Nalbantoglu, ILKe [1 ,5 ]
机构
[1] Washington Univ St Louis, Sch Med, Dept Pathol & Immunol, Lauren V Ackerman Lab Surg Pathol, St Louis, MO 63110 USA
[2] Baylor Univ, Baylor Ctr IBD, Med Ctr, Dallas, TX 75246 USA
[3] Washington Univ St Louis, Sch Med, Dept Surg, St Louis, MO 63110 USA
[4] Washington Univ St Louis, Sch Med, Dept Biostat, St Louis, MO 63110 USA
[5] Yale Univ, Dept Anat Pathol, Sch Med, New Haven, CT 06525 USA
关键词
Primary sclerosing cholangitis; Inflammatory bowel disease; Liver transplantation; Inflammation; Pathologic features; Clinical associations; INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; COLORECTAL NEOPLASIA; COLECTOMY; RISK;
D O I
10.3748/wjg.v26.i28.4126
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND Primary sclerosing cholangitis (PSC) associated inflammatory bowel disease (IBD) is a unique form of IBD (PSC-IBD) with distinct clinical and histologic features from ulcerative colitis (UC) and Crohn disease (CD). In patients with PSC and IBD, the severity of the two disease processes may depend on each other. AIM To study the histologic and clinical features of PSC patients with and without IBD. METHODS We assessed specimens from patients with UC (n= 28), CD (n= 10), PSC and UC (PSC-UC;n= 26); PSC and CD (PSC-CD;n= 6); and PSC and no IBD (PSC-no IBD;n= 4) between years 1999-2013. PSC-IBD patients were matched to IBD patients without PSC by age and colitis duration. Clinical data including age, gender, age at IBD and PSC diagnoses, IBD duration, treatment, follow-up, orthotopic liver transplantation (OLT) were noted. RESULTS PSC-UC patients had more isolated right-sided disease (P= 0.03), and less active inflammation in left colon, rectum (P= 0.03 andP= 0.0006), and overall (P= 0.0005) compared to UC. They required less steroids (P= 0.01) and fewer colectomies (P= 0.03) than UC patients. The PSC-CD patients had more ileitis and less rectal involvement compared to PSC-UC and CD. No PSC-CD patients required OLT compared to 38% of PSC-UC (P= 0.1). PSC-IBD (PSC-UC and PSC-CD) patients with OLT had severe disease in the left colon and rectum (P= 0.04). CONCLUSION PSC-UC represents a distinct form of IBD. The different disease phenotype in PSC-IBD patients with OLT may support liver-gut axis interaction, however warrants clinical attention and further research.
引用
收藏
页码:4126 / 4139
页数:14
相关论文
共 50 条
  • [31] Concomitant colitis associated with primary sclerosing cholangitis
    Uchida, N
    Ezaki, T
    Fukuma, H
    Tsutsui, K
    Kobara, H
    Matsuoka, M
    Masaki, T
    Watanabe, S
    Yoshida, M
    Maeta, T
    Koi, F
    Nakatsu, T
    Kuriyama, S
    [J]. JOURNAL OF GASTROENTEROLOGY, 2003, 38 (05) : 482 - 487
  • [32] Restorative Surgery in Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis Following a Colectomy
    Nordenvall, Caroline
    Olen, Ola
    Nilsson, Per Johan
    Ekbom, Anders
    Bottai, Matteo
    Myrelid, Par
    Bergquist, Annika
    [J]. INFLAMMATORY BOWEL DISEASES, 2018, 24 (03) : 624 - 632
  • [33] The impact of inflammatory bowel disease post-liver transplantation for primary sclerosing cholangitis
    Joshi, Deepak
    Bjarnason, Ingvar
    Belgaumkar, Ajay
    O'Grady, John
    Suddle, Abid
    Heneghan, Michael A.
    Aluvihare, Varuna
    Rela, Mohammed
    Heaton, Nigel
    Agarwal, Kosh
    [J]. LIVER INTERNATIONAL, 2013, 33 (01) : 53 - 61
  • [34] Recurrence of primary sclerosing cholangitis after liver transplantation - The Hungarian experience
    Gelley, Fanni
    Zadori, Gergely
    Gorog, Denes
    Kobori, Laszlo
    Fehervari, Imre
    Gaman, Gyorgy
    Gerlei, Zsuzsanna
    Nagy, Peter
    Sarvary, Eniko
    Nemes, Balazs
    [J]. INTERVENTIONAL MEDICINE AND APPLIED SCIENCE, 2014, 6 (01) : 16 - 18
  • [35] Temporal trends in colon neoplasms in patients with primary sclerosing cholangitis and ulcerative colitis
    Navaneethan, Udayakumar
    Venkatesh, Preethi G. K.
    Lashner, Bret A.
    Remzi, Feza H.
    Shen, Bo
    Kiran, Ravi P.
    [J]. JOURNAL OF CROHNS & COLITIS, 2012, 6 (08) : 845 - 851
  • [36] Liver outcomes following proctocolectomy in patients with primary sclerosing cholangitis and ulcerative colitis
    Ryan, Thomas
    Segal, Jonathan P.
    [J]. FRONTLINE GASTROENTEROLOGY, 2024, 15 (04) : 314 - 320
  • [37] Risk of colonic neoplasia after liver transplantation for primary sclerosing cholangitis
    Hanouneh, Ibrahim A.
    Macaron, Carole
    Lopez, Rocio
    Zein, Nizar N.
    Lashner, Bret A.
    [J]. INFLAMMATORY BOWEL DISEASES, 2012, 18 (02) : 269 - 274
  • [38] Primary Sclerosing Cholangitis in Genetically Diverse Populations Listed for Liver Transplantation: Unique Clinical and Human Leukocyte Antigen Associations
    Bowlus, Christopher L.
    Li, Chin-Shang
    Karlsen, Tom H.
    Lie, Benedicte A.
    Selmi, Carlo
    [J]. LIVER TRANSPLANTATION, 2010, 16 (11) : 1324 - 1330
  • [39] Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis?
    Marelli, Laura
    Xirouchakis, Elias
    Kalambokis, Georgios
    Cholongitas, Evangelos
    Hamilton, Mark I.
    Burroughs, Andrew K.
    [J]. GUT, 2011, 60 (09) : 1224 - 1228
  • [40] Pathogenesis and clinical spectrum of primary sclerosing cholangitis
    Gidwaney, Neelam G.
    Pawa, Swati
    Das, Kiron M.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (14) : 2459 - 2469